Podcasts about yale university school

What if it wasn’t spiders, heights, or flying… but grass, buttons, or your own reflection that made your hands clammy and your heart race? Meet Bettina, a romantic comedy author who avoids lawns at all costs; Marcos, who dreads reflections and shaves in the shower to escape the mirror; and Mark, who hasn’t worn a shirt with buttons since he was a kid. Connecticut psychologist Dr. David Tolin helps us understand how these fears develop, how they affect daily life, and why some people choose to confront their fears, while others simply adapt. Suggested episodes: Full house: The line between collecting, clutter, and hoarding disorder Are you very superstitious or just a little 'stitious'? Snakes in their mouths and venom in their veins: Why two snake pioneers do what they do GUESTS: Dr. David Tolin: Founder and Director of the Anxiety Disorders Center at The Institute of Living in Hartford, CT. He is also Adjunct Professor of Psychiatry at Yale University School of Medicine Bettina Hunt: a romantic comedy author based in the UK, who has a phobia of grass Marcos: a 24-year-old man from the Chicago area, who has a phobia of reflections Mark Cardia: a man based in Portugal, who has a phobia of buttons Support the show: https://www.wnpr.org/donateSee omnystudio.com/listener for privacy information.

In this compelling episode, Dr. Vera Tarman interviews Dr. Thomas Seyfried, a pioneer in the field of cancer metabolism. Dr. Seyfried challenges the mainstream view of cancer as a genetic disease and presents strong evidence that cancer is fundamentally a mitochondrial metabolic disorder. Dr. Thomas N. Seyfried is a distinguished American biologist and professor at Boston College, renowned for his pioneering work in cancer metabolism. With a Ph.D. in Genetics and Biochemistry from the University of Illinois, Urbana, and postdoctoral training in neurochemistry at Yale University School of Medicine, Dr. Seyfried has dedicated his career to exploring the metabolic underpinnings of cancer and other neurological diseases. Dr. Seyfried is best known for his groundbreaking book, Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer (2012), where he presents compelling evidence that cancer is primarily a mitochondrial metabolic disorder rather than a genetic one. This perspective builds upon the early 20th-century findings of Otto Warburg, who observed that cancer cells rely heavily on fermentation for energy production, even in the presence of oxygen—a phenomenon known as the Warburg effect. Dr. Seyfried's research suggests that targeting cancer's metabolic dependencies, such as glucose and glutamine, through dietary interventions like the ketogenic diet, could offer non-toxic therapeutic strategies. We explore: How cancer cells fuel themselves differently from healthy cells The connection between sugar, ultra-processed foods (UPFs), and cancer growth The Warburg Effect and the roles of glucose and glutamine in tumor development Whether refined sugar is carcinogenic like tobacco Why Dr. Seyfried believes ketogenic diets and caloric restriction can be powerful cancer therapies How his views align with metabolic psychiatry (Dr. Chris Palmer's Brain Energy) The controversial yet promising approach of "press-pulse" therapy The potential for preventing cancer through dietary change Follow: https://www.bc.edu/bc-web/schools/morrissey/departments/biology/people/faculty-directory/thomas-seyfried.html https://tomseyfried.com The content of our show is educational only. It does not supplement or supersede your healthcare provider's professional relationship and direction. Always seek the advice of your physician or other qualified mental health providers with any questions you may have regarding a medical condition, substance use disorder, or mental health concern.

For Hypertension Awareness Month, we are fortunate to have Dr. Robert Ostfeld, a cardiologist at Montefiore Medical Center, join us to talk about lifestyle approaches for treating – and preventing – high blood pressure. In this episode, Dr. Ostfeld explains the numbers, the symptoms – or lack of symptoms – and the associated risks. A self-confessed “reformed cardiologist,” he talks about how he saw his patients who adopted a plant-based diet significantly lower their blood pressure. Not ready to go totally plant-based? Dr. Ostfeld says simply adding more fruits, vegetables and whole grains to your diet can help lower not only your blood pressure but also your risk for heart disease, stroke and dozens of other conditions.   The Takeaway We want to hear from you! Please complete our survey: org/member-feedback. Drop us a line at our social media channels: Facebook// Instagram // YouTube. Get started on your health journey by making an appointment with your primary care physician to know your numbers. Get to know your numbers at 1199SEIUBenefits.org/healthyhearts. Find healthy recipes and meal-prep tips at 1199SEIUBenefits.org/food-as-medicine. Visit the Healthy Living Resource Center for wellness tips, information and resources; 1199SEIUBenefits.org/healthyliving. Get inspired by fellow members through our Members' Voices series: 1199SEIUBenefits.org/healthyliving/membervoices. Stop by our Benefits Channel to join webinars on building healthy meals, managing stress and more: 1199SEIUBenefits.org/videos. Visit our YouTube channel to view a wide collection of healthy living videos: youtube.com/@1199SEIUBenefitFunds/playlists. Sample our wellness classes to exercise body and mind: 1199SEIUBenefits.org/wellnessevents. Robert Ostfeld, MD, MSc, FACC, is the Director of Preventive Cardiology at Montefiore Health System and a Professor of Medicine at the Albert Einstein College of Medicine. Dr. Ostfeld treats patients with adult cardiovascular disease, including coronary artery disease, hypertension, hyperlipidemia and erectile dysfunction with a focus on prevention and treatment through lifestyle change. He works closely with his patients to help them adopt a plant-based diet. Dr. Ostfeld received his Bachelor of Arts in the Biologic Basis of Behavior from the University of Pennsylvania, graduating Summa Cum Laude and Phi Beta Kappa and his Doctor of Medicine from Yale University School of Medicine. He then did his medical internship and residency at the Massachusetts General Hospital and his Cardiology Fellowship and Research Fellowship in Preventive Medicine at Brigham and Women's Hospital, both teaching hospitals of Harvard Medical School. During his Cardiology Fellowship, he earned a Master's of Science in Epidemiology from the Harvard School of Public Health. Dr. Ostfeld's research focus is on cardiovascular disease prevention and reversal through lifestyle modification. Ongoing topics he investigates include the impact of plant-based nutrition on erectile function, coronary artery disease, angina and heart failure. His work has been published in peer-reviewed journals, books, articles, and clinical statements and has been presented nationally. Dr. Ostfeld is board certified in Cardiovascular Disease and Echocardiography, and he is a member of numerous professional societies, including the Physician's Committee for Responsible Medicine and the American College of Cardiology.

In this episode, Dr. Ryan Alexander joins the show to discuss findings from his new study Withdrawal Signs and Symptoms Among Patients Positive for Fentanyl With and Without Xylazine.    Dr. Ryan Alexander is an addiction medicine specialist and is currently the medical director for substance use services at McNabb Center in Knoxville, TN and is an assistant professor at the University of Tennessee Graduate School of Medicine. He completed medical school at the DeBusk College of Osteopathic Medicine in East Tennessee, his residency in preventive medicine and public health at Griffin Hospital/Yale School of Medicine, and a fellowship in addiction medicine at Yale University School of Medicine. In addition, he completed a Masters of Public Health at Yale School of Public Health. In addition to treating patients, Dr. Alexander conducts clinical research and has published multiple articles related to addiction medicine. He also regularly teaches medical students, residents, and other medical professionals about treating substance use disorders, reducing community stigma toward individuals with substance use disorders, and expanding access to medication treatments. - Article link: Withdrawal Signs and Symptoms Among Patients Positive for Fentanyl With and Without Xylazine

Send us a textDr. Arthur C. Evans Jr. is Chief Executive Officer of the American Psychological Association ( https://www.apa.org/about/apa/senior-staff/evans-bio ), the leading scientific and professional organization representing psychology in the United States. With more than 146,000 researchers, educators, clinicians, consultants, and students as members, APA promotes and disseminates psychological knowledge to benefit society and improve lives – a mission consistent with Dr. Evans' life work.Before joining APA in March 2017, Dr. Evans spent 12 years as commissioner of Philadelphia's Department of Behavioral Health and Intellectual disAbility Services. In that post, he led the transformation of that agency's approach to serving a wide range of individuals with complex needs. The transformation of the $1.5 billion Philadelphia system has relied heavily on public health strategies that contribute to better community health. Dr. Evans has emphasized a data-driven, population health approach to improve outcomes for people and increased system efficiency. Over his tenure, the agency saved more than $110 million that the city reinvested in improving and expanding services and employing innovative strategies to reach more people. The work in Philadelphia has become a national and international model, with over 25 states and more than a dozen countries having either visited the city or invited Evans to speak about the Philadelphia model.An unconventional leader, Dr. Evans has employed science, research, community activism, spirituality, traditional clinical care, policy, and cross-system collaborations to change the status quo. Dr. Evans approach gave voice to and empowered individuals and communities that have been historically marginalized. He ensured those with lived experiences were involved with every policy decision. He enlisted political and community leaders, grassroots organizations, academic institutions and advocates in a citywide commitment to think differently about behavioral health and intellectual disabilities.Dr. Evans has been honored nationally and internationally for his work. In 2015, he was recognized as an “Advocate for Action” by the White House Office of National Drug Control Policy. In 2013, he received the American Medical Association's top government service award in health care, the Dr. Nathan Davis Award for Outstanding Government Service. In 2017, he received the Visionary Leadership Award from the National Council of Behavioral Health and was inducted into the Florida Atlantic University Alumni Hall of Fame. His work as a strong advocate for social justice has led to his receiving three different awards named for the Rev. Martin Luther King Jr.Dr. Evans has held faculty appointments at the University of Pennsylvania Perelman School of Medicine, the Philadelphia College of Osteopathic Medicine, and the Drexel School of Public Health. He also held a faculty appointment at the Yale University School of Medicine.Dr. Evans holds a doctorate in clinical/community psychology from the University of Maryland and a master's degree in experimental psychology from Florida Atlantic University, where he also completed his undergraduate work.#ArthurEvans #AmericanPsychologicalAssociation #Psychology #MentalHealth #AddictionServices #RecoveryOrientedSystemOfCare #BehavioralHealth #PhiladelphiaModel #PennCollaborative #BeckCommunityInitiative #CognitiveBehavioralTherapy #EvidenceBasedPractices #ImplementationScientists #CommunityPsychology #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

In this episode, Dr. Rob Whitfield, a board-certified plastic surgeon, sits down with Dr. Esra Cavusoglu, a psychologist and certified addiction therapist, to chat about how addiction, hormone health, and overall wellness all connect. Dr. Whitfield dives into the topic of breast implant illness, going over its symptoms and the different treatment options available, while emphasizing the importance of a multimodal approach to managing pain after surgery. Dr. Cavusoglu shares her unique methods for treating addiction, focusing on how hormone imbalances and trauma play a role. Tune in to hear more about the need for a holistic approach to health, integrating both physical and mental health care to boost patient outcomes and enhance overall well-being. Connect with Dr. Esra Cavusoglu Instagram (https://www.instagram.com/esracavusoglu/reels/) LinkedIn (http://linkedin.com/in/esra-m-cavusoglu-phd-casac-cac-77548021) Website (https://www.longevilab.com/en/c/longevity) Show Highlights: Discussion on Cognitive Impairment (00:02:20) Cognitive impairment and its relevance in addiction treatment Unique Methods in Addiction Treatment (00:02:58) Treating addiction through hormone level assessments and comprehensive bloodwork Pain Management Post-Surgery (00:10:12) Strategies for managing pain and avoiding opioid dependence after surgery High-Performance Addiction (00:14:22) Addiction patterns in high-functioning individuals and their coping mechanisms Young Patient Demographics (00:19:03) Rising rates of eating disorders and alcoholism among younger patients Body Dysmorphia Concerns (00:20:21) Prevalence of body dysmorphia and early cosmetic procedures in young women Recognizing Addiction in Loved Ones (00:28:42) Identifying addiction through behavioral changes rather than substance use frequency Bio: Dr. Cavusoglu Trained both in the United States and internationally, Dr. Esra Çavuşoğlu is a doctor in psychology and a certified addiction therapist in the State of New York. She formerly held a position on the Clinical Advisory Board of the Yale University School of Medicine and served as an Advisor for International Development with the Yale Program on Supervision. Dr. Esra Çavuşoğlu has participated in numerous international medical conferences and events. Some of the prominent organizations include serving as a moderator at the event organized by the United Nations Office on Drugs and Crime (UNODC) in Vienna, Austria, in 2016. Dr. Çavuşoğlu also acted as a panelist at the Asia Pacific Behavioral and Addiction Medicine (APBAM) Conference held in Singapore in 2013. Dr. Çavuşoğlu continues to treat her patients. In her capacity as the senior supervisor at the Oya Bahadır Yüksel Rehabilitation Center in Gaziantep, Turkey, Dr. Esra Çavuşoğlu designed and implemented the Turkey Model of Rehabilitation, which has since become the standard in the country. Prior to this role, she served for two years as the Vice President of Operations at the Gaziantep Center, where she collaborated closely with key Turkish government and health consultancy officials. She has made significant contributions to the field of addiction treatment in Turkey. Her articles on this topic have been honored with Presidential Recognition. She has presented on important subjects such as adolescent substance abuse treatment, including engagements in the United States, Turkey, and Singapore. Dr. Çavuşoğlu established the Contemporary Addiction Studies Association (ÇABAÇAD) to combat the growing addiction problem of Turkiye. In her power, her desire is to spread the science of addiction to the field and support institutions that are in need of building residential and outpatient programs, as well as create training curricula. Links and Resources Let's Connect Podcast: https://podcasts.apple.com/gb/podcast/breast-implant-illness/id1678143554 Spotify: https://open.spotify.com/show/1SPDripbluZKYsC0rwrBdb?si=23ea2cd9f6734667 TikTok: https://www.tiktok.com/@drrobertwhitfield?t=8oQyjO25X5i&r=1 IG: https://www.instagram.com/breastimplantillnessexpert/ FB: https://www.facebook.com/DrRobertWhitfield Linkedin: https://www.linkedin.com/in/dr-robert-whitfield-md-50775b10/ X: https://x.com/rob_whitfieldmd Read this article - https://www.breastcancer.org/treatment/surgery/breast-reconstruction/types/implant-reconstruction/illness/breast-implant-illness Shop: https://drrobssolutions.com SHARP: https://www.harp.health NVISN Labs - https://nvisnlabs.com/ Get access to Dr. Rob's Favorite Products below: Danger Coffee - Use our link for mold free coffee - https://dangercoffee.com/pages/mold-free-coffee?ref=ztvhyjg JASPR Air Purifier - Use code DRROB for the Jaspr Air Purifier - https://jaspr.co/ Echo Water - Get high quality water with our code DRROB10 - https://echowater.com/ BallancerPro - Use code DRROBVIP for the world's leader in lymphatic drainage technology - https://ballancerpro.com Ultrahuman - Use code WHITFIELD10 for the most accurate wearable - https://www.ultrahuman.com/ring/buy/us/?affiliateCode=drwhitfield

In this episode, join moderator Brea Burmeister and experts Dr. Scott Weiner and Dr. Arjun Venkatesh as they explore how quality measures can transform opioid use disorder (OUD) care in emergency departments. Discover innovative metrics, quality improvement initiatives, and EHR data integration to optimize patient outcomes. Learn about overcoming barriers like stigma and resource shortages and get key recommendations from recent OUD treatment studies. Perfect for healthcare professionals and anyone interested in advancing OUD care.What You'll Learn:Challenges and opportunities of addressing the opioid epidemic in emergency medicineACEP's work on metrics and the development of quality improvement measuresKey quality initiatives to enhance OUD care and reduce harmThe barriers to adopting these initiatives and strategies to overcome themRecommendations based on recent studies in OUD treatment and medicationMODERATOR: Brea BurmeisterMember, CHIME Opioid Task ForceBio: With 23 years in healthcare, Brea specializes in managing relationships within Integrated Delivery Network (IDN) Health Systems, regional Group Practices, and Specialty Pharmacy accounts. She strengthens value-based care models by developing strategic plans, analyzing performance data, improving care coordination, and implementing process improvements. Brea's work enhances patient outcomes and experiences while reducing costs. Additionally, her volunteer work with the Opioid Task Force reflects her commitment to public health advocacy and community well-being.GUEST: Scott Weiner, MD, MPH, FAAEM, FACEP, FASAMEmergency and Addiction Medicine Physician, Brigham and Women's HospitalAssociate Professor, Harvard Medical SchoolCo-chair, Clinical Advisory subcommittee, CHIME Opioid Task ForceBio: Dr. Weiner is the McGraw Distinguished Chair in the Department of Emergency Medicine at Brigham and Women's Hospital and an Associate Professor of Emergency Medicine at Harvard Medical School. He is board-certified in emergency medicine and addiction medicine. He is an active researcher, working on multiple projects that focus on prevention and treatment of opioid use disorder.GUEST: Arjun Venkatesh, MD, MBA, MHSChair, Department of Emergency Medicine, Yale University School of MedicineChief, Emergency Medicine, Yale New Haven HospitalBio: Dr. Venkatesh is Chair and Chief of Emergency Medicine at the Yale University School of Medicine and Yale New Haven Hospital. He has received over $ 12 million in funding by the NIH, CMS, AHRQ, and CDC to develop measures and interventions that improve acute care outcomes and value. He has supported CMS's development of the Overall Hospital Quality Star Ratings, has led the development of quality measures for the Clinical Emergency Data Registry, and is PI of the Emergency Quality Network (E-QUAL). His work has produced over 200 publications and been implemented in numerous national quality and value programs. He is a graduate of Northwestern University School of Medicine, a proud graduate of the HAEMR Class of 2012 often referred to as the Greatest Class Ever, and completed the RWJF Clinical Scholars Program at Yale.Additional Resources:ACEP E-QUAL opioid initiativeCedr

For episode 261, Dr. Jenny Taitz returns to the Metta Hour for our Anxiety Series. Jenny is a clinical psychologist and an assistant clinical professor in psychiatry at the University of California, Los Angeles. She completed her fellowship in psychology at Yale University School of Medicine and achieved board certifications in cognitive behavioral therapy and dialectical behavior therapy. In addition to treating clients in her private therapy practice, LA CBT DBT, she is the author of How to Be Single and Happy and End Emotional Eating. Her new book, Stress Resets: How to Soothe Your Body and Mind in Minutes, is now available in paperback, ebook, and audiobook formats. In this episode, Sharon and Jenny discuss:Jenny's approach to anxietyEmotions are contagiousThe superpower of emotional regulationCultivating an inner lifeThree-point check-inHow to break-up with overthinkingGetting groundingCognitive diffusionNaming your inner criticSitting with uncertaintyBuilding a hope kitBox-breathingLovingkindness Doing good deedsExamining assumptionsSurfing emotional urgesSharon closes with a hypothetical situation about anxiety which Jenny advises on. You can learn more about Jenny's work and get a copy of her book, Stress Resets, on her website.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Small cell lung cancer (SCLC) is a smoking-related malignancy that presents at an advanced stage in 70% of patients. Author Anne C. Chiang, MD, PhD, of the Yale University School of Medicine joins JAMA Senior Editor Karen Lasser, MD, MPH, to discuss the epidemiology, treatment, and prognosis of SCLC. Related Content: Small Cell Lung Cancer

On this episode of the podcast, Yale University School of Public Health Professor Emeritus Dr. Harvey Risch discusses the critical lessons learned from the COVID-19 pandemic. He breaks down the inaccuracies in early information, the suppression of dissenting scientific voices, and the failures of policies like lockdowns and mask mandates. Dr. Risch highlights the effectiveness of early treatments, such as hydroxychloroquine, which showed a 75% reduction in mortality in early studies and explained the rationale behind the Great Barrington Declaration's approach to protecting high-risk individuals while allowing society to function normally.Furthermore, Dr. Risch shares his skepticism about the potential for bird flu to become the next pandemic and underscores the need for objective evidence in restoring public trust in health authorities.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Mark Mamula, an immunologist and professor at Yale University School of Medicine, to discuss his groundbreaking work in canine cancer immunotherapy. Dr. Mamula shares how his background in autoimmune diseases led him to develop an experimental vaccine targeting EGFR and HER2 proteins in dogs with cancer. He explains the science behind this therapy, its clinical trial progress, and its potential to improve survival outcomes for cancers such as osteosarcoma and hemangiosarcoma. They also explore the challenges of bringing new therapies to veterinary medicine, the role of combination treatments, and the importance of accessible, cost-effective options for pet owners. Tune in for an insightful conversation on the evolving landscape of canine cancer treatment and the promising future of immunotherapy.

BUFFALO, NY — February 26, 2025 — A new #research paper was #published in Aging (Aging-US) on January 27, 2025, in Volume 17, Issue 1, titled “Age-invariant genes: multi-tissue identification and characterization of murine reference genes.” Aging is a process driven by changes in gene activity, but researchers from Yale University School of Medicine and Altos Labs, led by first author John T. González and corresponding author Albert T. Higgins-Chen, have identified a set of genes that remain unchanged throughout the aging process. This discovery could improve the accuracy of aging research and provide insights into why some genes stay unchanged while others decline. “Reference genes have mostly been identified and validated in young organisms, and no systematic investigation has been done across the lifespan.” The study looked at gene activity in 17 different tissues in mice, from 1 month old to over 21 months old. Scientists used advanced bioinformatic analysis methods to analyze RNA sequencing data. They found nine genes that stayed the same across all tissues, as well as other genes that remained stable in specific tissues. These genes are usually shorter and have special DNA regions called CpG islands, which may help cells stay healthy and resist aging. Their stability throughout aging was confirmed by analyzing different datasets and using RT-qPCR. One of the most significant findings is that these stable genes are linked to essential cellular functions, such as mitochondrial activity and protein maintenance. This challenges the common belief that all aspects of aging involve gene dysregulation. Instead, the findings suggest that some cellular processes may naturally resist aging, leading the way for new research on longevity and potential anti-aging therapies. “Biological processes that change with age and those that resist age-related dysregulation are two sides of the same coin, and both will need to be investigated to fully understand aging.” Another key finding is that commonly used reference genes, such as GAPDH and ACTB, fluctuate with age, making them unreliable for aging studies. No single classical reference gene was found to be stable across all tissues. Researchers often use these reference genes as a control to measure gene activity, but if their expression changes over time, it can lead to inaccurate results. By identifying new, stable reference genes, this study provides scientists with better tools for studying aging-related diseases, regenerative medicine, and longevity science. Understanding how certain genes remain unchanged throughout life suggests that they may play a protective role in aging and could potentially be used to develop treatments that slow down age-related decline. While further research is needed, this discovery sets a new standard for measuring gene activity in aging studies and could have a significant impact on aging research and medicine. DOI - https://doi.org/10.18632/aging.206192 Corresponding author - Albert T. Higgins-Chen - a.higginschen@yale.edu About Aging-US The mission of the journal is to understand the mechanisms surrounding aging and age-related diseases, including cancer as the main cause of death in the modern aged population. The journal aims to promote 1) treatment of age-related diseases by slowing down aging, 2) validation of anti-aging drugs by treating age-related diseases, and 3) prevention of cancer by inhibiting aging. (Cancer and COVID-19 are age-related diseases.) Please visit our website at https://www.Aging-US.com​​ and connect with us: Facebook - https://www.facebook.com/AgingUS/ X - https://twitter.com/AgingJrnl Instagram - https://www.instagram.com/agingjrnl/ YouTube - https://www.youtube.com/@AgingJournal LinkedIn - https://www.linkedin.com/company/aging/ Pinterest - https://www.pinterest.com/AgingUS/ Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc Media Contact 18009220957 MEDIA@IMPACTJOURNALS.COM

“Facing Denial, Embracing Vulnerability” Join me and my guest Dr. Andrew G. Kadar. Dr. Kadar, is a renowned physician at Cedars-Sinai Medical Center and was used to taking care of patients—not being one himself. But just as he was embarking on a new marriage, a few episodes of minor chest pain sent this healthy, successful anesthesiologist to his doctor's office, where he received a shocking diagnosis: he had severe heart disease and required immediate open-heart surgery. With extraordinary wisdom and unflinching candor Dr. Kadar describes his unexpected journey as a man in seemingly excellent health into the dire realm of illness and subsequent recovery. Dr. Kadar is a physician at Cedars-Sinai Medical Center, a Diplomate of the American Board of Anesthesiology, and a Fellow of the American Society of Anesthesiologists. He graduated from the Yale University School of Medicine and completed his residency at Stanford and Harvard Universities (Massachusetts General Hospital). He has served on the faculties of the UCLA School of Medicine, Charles Drew University, and Cedars-Sinai Medical Center. He has appeared on Good Morning America and NBC Nightly News, as well as Air Talk with Larry Mantle and The Dennis Prager Show. Summary In this episode, Dr. Andrew Kadar shares his unexpected journey through a significant health challenge, exploring themes of denial, vulnerability, and the importance of communication. He reflects on the lessons learned from his experience as both a doctor and a patient, emphasizing the need for connection, appreciation, and a positive impact on others. The discussion also touches on the role of caregivers and the shift in perspective regarding life and mortality. Takeaways Denial can hinder our ability to face health challenges. Vulnerability fosters connection and understanding. Communication is key in patient-caregiver relationships. Health challenges can lead to personal growth and self-discovery. It's important to appreciate the support of caregivers. Life's unexpected events can be viewed as opportunities. A positive mindset can influence recovery and resilience. We should strive to make a positive impact on others. Understanding mortality can shift our life priorities. Everything in life eventually needs to be shared and distributed. Learn more about your ad choices. Visit megaphone.fm/adchoices

Inverse psoriasis is more challenging to treat and to keep under control. Learn more as we uncover inverse psoriasis from what it is, typical symptoms and sites, other potential diseases, to being a risk factor for psoriatic arthritis, and what treatments are used either alone or in combination with dermatologist Dr. Jeffrey Cohen, Director, Psoriasis Treatment Program at Yale University School of Medicine and moderator Kaitlin Walden, RN. 

Arjun Venkatesh, MD, MBA, MHS - Yale University School Of Medicine by SAEM

Arjun Venkatesh, MD, MBA, MHS - Yale University School Of Medicine by SAEM

Join us for an empowering and insightful conversation as Dr. Jennie Berkovich sits down with Dr. Amy Comander, a leading breast oncologist and advocate for patient-centered care. In this episode, Dr. Comander shares her expertise on the latest advancements in breast cancer detection, treatment, and survivorship. Discover how personalized medicine and multidisciplinary care are revolutionizing outcomes for breast cancer patients. Dr. Comander also delves into the critical role of lifestyle medicine—including exercise, nutrition, and mindfulness—in promoting healing and resilience. With her unique perspective as a passionate runner and physician, Dr. Comander draws inspiring parallels between running and the cancer journey, offering hope and practical advice for patients and their families navigating a diagnosis. Whether you're a healthcare professional, patient, or advocate, this episode will leave you informed, inspired, and ready to run the race toward better cancer care. Don't miss it! Dr. Amy Comander specializes in the care of women with breast cancer.  Dr. Comander is Medical Director of the Mass General Cancer Center in Waltham, where she also serves as Director of Breast Oncology and Cancer Survivorship at the Mass General Cancer Center in Waltham and at Newton Wellesley Hospital. She is an Instructor in Medicine at Harvard Medical School. She received her undergraduate degree and a master's degree in Neuroscience at Harvard University. She received her medical degree at Yale University School of Medicine. She completed her Internal Medicine residency training and Hematology-Oncology fellowship training at Beth Israel Deaconess Medical Center and Harvard Medical School. She is board certified in Hematology and Medical Oncology, and she is a Diplomat of the American Board of Lifestyle Medicine. _________________________________________________ Sponsor the JOWMA Podcast! Email digitalcontent@jowma.org Become a JOWMA Member! www.jowma.org Follow us on Instagram! www.instagram.com/JOWMA_org Follow us on Twitter! www.twitter.com/JOWMA_med Follow us on Facebook! https://www.facebook.com/JOWMAorg Stay up-to-date with JOWMA news! Sign up for the JOWMA newsletter! https://jowma.us6.list-manage.com/subscribe?u=9b4e9beb287874f9dc7f80289&id=ea3ef44644&mc_cid=dfb442d2a7&mc_eid=e9eee6e41e

Dr. Renato Polimanti is an Associate Professor of Psychiatry, and he also has appointments in Biomedical Informatics & Data Science, as well as Chronic Disease Epidemiology at the Yale University School of Medicine, the School of Public Health, and the Wu Tsai Institute. Research in Renato's lab examines human genetics from different perspectives. His current projects aim to understand the molecular mechanisms that predispose certain individuals to develop psychiatric disorders and symptoms, and the links between co-morbid conditions like cardiovascular disease. He is particularly interested in internalizing psychiatric disorders, which include depression, anxiety, and post-traumatic stress disorder. Some of Renato's favorite pastimes include reading, traveling to different countries, and trying various kinds of foods. He is a big fan of authentic Italian food as well as sushi, and Renato has explored many of the local restaurants in New Haven, Connecticut. Renato completed his bachelor's degree (BSc), Master's degree (MSc), and PhD at the University of Rome Tor Vergata. Afterwards, he conducted postdoctoral research at the Yale University School of Medicine before joining the faculty at Yale. He has received a variety of awards and honors for his work, including the One Mind Rising Star Computational Psychiatry Research Award, an Explorers Award from the Simons Foundation Autism Research Initiative, the Early Career Investigator Award from the Million Veteran Program, and Young Investigator Awards from the journal Genes, the American Foundation for Suicide Prevention, the Brain & Behavior Research Foundation, and the International Society of Applied Biological Sciences. In our interview, Renato shares more about his life and science.

In this episode of the Productivity Smarts Podcast, host Gerald J. Leonard sits down with Dr. Andrew Kadar, a physician at Cedars-Sinai Medical Center. Dr. Kadar opens up about his personal journey of resilience after being diagnosed with heart disease, sharing the challenges he faced and the valuable lessons he learned along the way. He discusses how mindset, adaptability, and seeking help were key to his recovery. Dr. Kadar also reveals how his experience as a patient has deepened his empathy and transformed his approach to patient care.  Tune in to hear Dr. Kadar's powerful insights on overcoming adversity and the critical role of empathy in medicine.  What We Discuss [00:02:01] Introduction to Dr. Andrew Kadar [00:11:09] Vulnerability in healthcare [00:13:49] Trusting caregivers [00:18:32] Adapting to challenges [00:22:23] Understanding patient perspective [00:24:50] Dual perspective in writing [00:27:00] Reflection and perspective shift [00:29:10] Caregiver consideration Notable Quotes [00:06:30] "My story is very similar to lots of other patient stories. First of all, I thought I was perfectly healthy... I had no expectation that I would, at a relatively young age, all of a sudden have symptoms of heart disease and end up having what's known as the widowmaker." - Dr. Andrew Kadar [00:12:09] "Of course, the thing that strikes immediately is the vulnerability that you're under. Because as a doctor or as an advisor, you're not really vulnerable to anywhere near the degree that a patient is." - Dr. Andrew Kadar [00:16:07] "Getting better is a cooperative effort. You need your caretakers to be guiding you, but you have to put the work in to help yourself get better." - Dr. Andrew Kadar [00:26:01] "I never say to patients after surgery that they're going to have no pain. I tell them that we'll be able to alleviate their pain to make it bearable, but any time you have a major surgery, you're unfortunately going to have to go through some struggle." - Dr. Andrew Kadar [00:29:10] "Having a major illness is a family affair. It affects your spouse, your colleagues, and it's important to be considerate of your caretakers and to be appreciative of them." - Dr. Andrew Kadar Our Guest Dr. Andrew G. Kadar is a distinguished anesthesiologist affiliated with Cedars-Sinai Medical Center in West Hollywood, California. He earned his medical degree from Yale University School of Medicine and completed residencies at both Stanford University and Harvard University's Massachusetts General Hospital. Throughout his career, Dr. Kadar has served on the faculties of the UCLA School of Medicine, Charles Drew University, and Cedars-Sinai Medical Center. In addition to his medical practice, he has pursued literary studies through the UCLA Writers' Program and the Antioch University MFA writing program. Dr. Kadar is the author of "Getting Better: A Doctor's Story of Resilience, Recovery, and Renewal," a book that offers a unique perspective on the patient experience from a physician's viewpoint.  His contributions to both medicine and literature underscore his commitment to patient care and the human aspects of medical practice. Resources and Links Dr Andrew G. Kadar M.D. LinkedIn - https://www.linkedin.com/in/andrew-kadar-5b1b1113 Book - Getting Better: A Doctor's Story of Resilience, Recovery, and Renewal Productivity Smarts Podcast Website - productivitysmartspodcast.com Gerald J. Leonard Website - geraldjleonard.com Turnberry Premiere website - turnberrypremiere.com Scheduler - vcita.com/v/geraldjleonard   Kiva is a loan, not a donation, allowing you to cycle your money and create a personal impact worldwide. https://www.kiva.org/lender/topmindshelpingtopminds  

Research shows that Tobacco 21 (T21) policies with a minimum legal age to purchase tobacco products of 21 years reduce youth smoking, yet their potential long-term impact varies across US states. Jamie Tam, MPH, PhD, of the Yale University School of Public Health discusses these findings with JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD. Related Content: US Tobacco 21 Policies and Potential Mortality Reductions by State

This week, we are joined by Dr. Ami Klin, the Director of the Marcus Autism Center and a leading expert in autism research. We will be discussing his groundbreaking work with Dr. Warren Jones, utilizing eye-tracking technology to visualize and measure social engagement in individuals with autism. Ami Klin, Ph.D. is the Georgia Research Alliance Eminent Scholar Professor and Chief of the Division of Autism and Developmental Disabilities at Emory University School of Medicine, and Director of the Marcus Autism Center at Children's Healthcare of Atlanta. He obtained his Ph.D. from the University of London, and completed clinical and research post-doctoral fellowships at the Yale Child Study Center. He directed the Autism Program at the Yale Child Study Center, Yale University School of Medicine, until 2010, where he was the Harris Professor of Child Psychology & Psychiatry. The Marcus Autism Center is one of the largest centers of clinical care and science focused on autism and related conditions in the country. Dr. Klin's primary research activities focus on social mind and social brain, and on developmental aspects of autism from infancy through adulthood. These studies include a longstanding collaboration with Dr. Warren Jones focused on novel science-based technologies developed and clinically validated to address limited access to high quality early diagnosis and assessment of autism. He is the author of over 250 publications in the field of autism and related conditions.  Download to learn more! ............................................................... Autism weekly is now found on all of the major listening apps including apple podcasts, google podcasts, stitcher, Spotify, amazon music, and more. Subscribe to be notified when we post a new podcast. Autism weekly is produced by ABS Kids. ABS Kids is proud to provide diagnostic assessments and ABA therapy to children with developmental delays like Autism Spectrum Disorder. You can learn more about ABS Kids and the Autism Weekly podcast by visiting abskids.com.  

Dr. Nachi (Michael) Felt, Ph.D. is an ADHD & Executive Functioning specialist who has lectured at Yale University School of Medicine, and is a professor at Columbia University where he teaches Psychopathology and co-directs the Cognition and Neuroscience Research Lab. In this episode, Dr. Felt talks about the ADHD 'Cycle of Ambiguity,' and introduces his 'Felt Five' method for creating clarity and aligning with personal values.Learn more about Dr. Felt and his work at adhddoctor.org. Watch this episode on YouTubeWant help with your ADHD? Join FOCUSED!Have questions for Kristen? Call 1.833.281.2343Hang out with Kristen on Instagram and TikTok

Today, Hunter is joined by Professor Stephen Bright to discuss his new book, the Fear of Too Much Justice. Over decades of work as an attorney, Steve has been a leading voice against the death penalty and in support of major overhauls to our criminal legal system. Today, Steve joins the show to discuss how the Fear of Too Much Justice is stopping people from reforming our criminal legal system.     Guests: Stephen Bright, Professor of Law, Yale University School of Law   Resources: Stephen Bright's Faculty Page https://law.yale.edu/stephen-b-bright Fear of Too Much Justice https://www.thefearoftoomuchjustice.com/       Contact Hunter Parnell:                                 Publicdefenseless@gmail.com  Instagram @PublicDefenselessPodcast Twitter                                                                 @PDefenselessPod www.publicdefenseless.com  Subscribe to the Patron www.patreon.com/PublicDefenselessPodcast  Donate on PayPal https://www.paypal.com/donate/?hosted_button_id=5KW7WMJWEXTAJ Donate on Stripe https://donate.stripe.com/7sI01tb2v3dwaM8cMN Trying to find a specific part of an episode? Use this link to search transcripts of every episode of the show! https://app.reduct.video/o/eca54fbf9f/p/d543070e6a/share/c34e85194394723d4131/home  

The NIEHS Superfund Research Program (SRP) is hosting a Risk e-Learning webinar series focused on using artificial intelligence (AI) and machine learning to advance environmental health research. The series will feature SRP-funded researchers, collaborators, and other subject-matter experts who aim to better understand and address environmental health issues by applying AI and machine learning approaches to complex issues. Recent advances in AI and machine learning methods show promise to improve the accuracy and efficiency of environmental health research. Over the course of three sessions, presenters will discuss how they use AI and machine learning approaches to improve chemical analysis, characterize chemical risk, understand microbial ecosystems, develop technologies for contaminant removal, and more. In the second session ML & AI Applications to Environmental Engineering Contaminants & Bioremediation, invited presenters will discuss how they apply machine learning and artificial intelligence to environmental engineering applications including contaminants and bioremediation using biosensors, microbiome compositions, and screening tools. To learn about and register for the other sessions in this webinar series, please see the SRP website. Kei-Hoi Cheung, Ph.D., has an extensive history in data science, and has leveraged that expertise to lead natural language processing (NLP) projects in annotating, extracting, and retrieving environmental exposure data. He will present on the use of these NLP methods combined with ontologies in the in the context of scientific literature on emerging water contaminants. Mohammad Soheilypour, Ph.D., will discuss the application of a suite of computational methods to identify and predict microbial metabolism of various chemical compounds, with a focus on gut and environmental microbiomes. Specifically, he will cover the potential application of machine learning models in this context and their integration with other computational methods to enhance both accuracy and utility. Paul Westerhoff, Ph.D., will highlight the work of his research team utilizing and comparing two advanced multiple data imputation techniques, AMELIA and MICE algorithms, to fill gaps in sparse groundwater quality datasets to support State agencies in prioritizing future sampling activities. Historic water quality databases are often sparse due to financial budgets for collection and analysis, posing challenges in evaluating exposure or water treatment effectiveness — and this project aims to account for those by accurately assessing and managing risks associated with inorganic pollutants using this technology. Speakers:Kei-Hoi Cheung, Ph.D., Yale University School of MedicineMohammad Soheilypour, Ph.D., Nexilico Inc.Paul Westerhoff, Ph.D., Arizona State UniversityModerator: Rodrigo Rimando, U.S. Department of Energy To view this archive online or download the slides associated with this seminar, please visit http://www.clu-in.org/conf/tio/SRP-ML-AI2_112024/

The NIEHS Superfund Research Program (SRP) is hosting a Risk e-Learning webinar series focused on using artificial intelligence (AI) and machine learning to advance environmental health research. The series will feature SRP-funded researchers, collaborators, and other subject-matter experts who aim to better understand and address environmental health issues by applying AI and machine learning approaches to complex issues. Recent advances in AI and machine learning methods show promise to improve the accuracy and efficiency of environmental health research. Over the course of three sessions, presenters will discuss how they use AI and machine learning approaches to improve chemical analysis, characterize chemical risk, understand microbial ecosystems, develop technologies for contaminant removal, and more. In the second session ML & AI Applications to Environmental Engineering Contaminants & Bioremediation, invited presenters will discuss how they apply machine learning and artificial intelligence to environmental engineering applications including contaminants and bioremediation using biosensors, microbiome compositions, and screening tools. To learn about and register for the other sessions in this webinar series, please see the SRP website. Kei-Hoi Cheung, Ph.D., has an extensive history in data science, and has leveraged that expertise to lead natural language processing (NLP) projects in annotating, extracting, and retrieving environmental exposure data. He will present on the use of these NLP methods combined with ontologies in the in the context of scientific literature on emerging water contaminants. Mohammad Soheilypour, Ph.D., will discuss the application of a suite of computational methods to identify and predict microbial metabolism of various chemical compounds, with a focus on gut and environmental microbiomes. Specifically, he will cover the potential application of machine learning models in this context and their integration with other computational methods to enhance both accuracy and utility. Paul Westerhoff, Ph.D., will highlight the work of his research team utilizing and comparing two advanced multiple data imputation techniques, AMELIA and MICE algorithms, to fill gaps in sparse groundwater quality datasets to support State agencies in prioritizing future sampling activities. Historic water quality databases are often sparse due to financial budgets for collection and analysis, posing challenges in evaluating exposure or water treatment effectiveness — and this project aims to account for those by accurately assessing and managing risks associated with inorganic pollutants using this technology. Speakers:Kei-Hoi Cheung, Ph.D., Yale University School of MedicineMohammad Soheilypour, Ph.D., Nexilico Inc.Paul Westerhoff, Ph.D., Arizona State UniversityModerator: Rodrigo Rimando, U.S. Department of Energy To view this archive online or download the slides associated with this seminar, please visit http://www.clu-in.org/conf/tio/SRP-ML-AI2_112024/

I'm joined today by Dr. Katrina Furey, a board-certified adult psychiatrist in women's mental health and reproductive psychiatry. We are diving into understanding how hormones impact mental health in the perinatal period and at other times in a woman's life cycle. Join us to learn more! Dr. Furey is a clinical instructor at the Yale University School of Medicine Department of Psychiatry and has Sound Psychiatry, a private practice in Guilford, Connecticut. She is a consultant for Connecticut's Access Mental Health for Moms Hotline, offering psychiatric expertise and consultation to medical providers treating women for mental health or substance abuse issues. She also co-hosts the Analyze Scripts podcast, which analyzes the depiction of mental health in fictional TV shows and films. Dr. Furey just launched Repro Psych Academy, a comprehensive series of online courses designed to empower all healthcare providers to feel more confident in diagnosing and managing women's mental health conditions related to hormonal shifts from menses to menopause.  Show Highlights: Dr. Furey's perspective on women's mental health and reproductive psychiatry Understanding the specialty of repro psych Hormones, depression, and anxiety How women are judged and dismissed for their “hormones” and what their bodies do PMS, PMDD, and PNMH Information about hormonal shift differences and birth control Determining if a medication is best for you, what to try, and when to switch Dr. Furey's efforts to train more providers to help more women Resources: Connect with Dr. Katrina Furey: Sound Psychiatry, Analyze Scripts podcast, Repro Psych Academy, and Instagram Call the National Maternal Mental Health Hotline at 1-833-TLC-MAMA or visit cdph.ca.gov Please find resources in English and Spanish at Postpartum Support International, or by phone/text at 1-800-944-4773. There are many free resources, like online support groups, peer mentors, a specialist provider directory, and perinatal mental health training for therapists, physicians, nurses, doulas, and anyone who wants to be more supportive in offering services.  You can also follow PSI on social media: Instagram, Facebook, and most other platforms Visit www.postpartum.net/professionals/certificate-trainings/ for information on the grief course.   Visit my website, www.wellmindperinatal.com, for more information, resources, and courses you can take today! If you are a California resident looking for a therapist in perinatal mental health, email me about openings for private pay clients!

Public Health Careers podcast episode with Dr. Sitara Weerakoon, PhD MPH

This week, Pete and Nikki sit down with Dr. Michael Felt to learn more about Delayed Sensory Affect (DSA). Ever find yourself so immersed in hyperfocus that basic needs fall by the wayside, only to erupt into chaos later? This could be a hidden ADHD struggle you've been facing.We know our brains can be overwhelmed by constant stimuli and misinterpret sensory cues. This can lead to dramatic emotional responses. Through the amusing "I have to make" model, he illustrates how this affects both children and adults, becoming a silent disruptor in our daily lives.The discussion turns raw as Pete opens up about the emotional toll of transitioning from work to home, highlighting a common yet unspoken burden for many ADHD adults. Nikki challenges listeners to recognize these patterns and take actionable steps to soften transitions with intention.Dr. Felt is an ADHD & Executive Functioning specialist who has lectured at Yale University School of Medicine, and is a professor at Columbia University, where he teaches Psychopathology. He's also, once again, a new dad. Congrats, Michael, from all of us, to all of you.Links & NotesPatreon for The ADHD PodcastDiscord CommunityDr. Michael Felt's WebsiteDig into the podcast Shownotes Database (00:00) - Welcome to Taking Control: The ADHD Podcast (03:34) - Introducing Dr. Michael Felt (04:28) - What is DSA? (31:32) - A Toast to our ADHD --It's Time to Live Unapologetically — The Book is Available Now!Our new book, Unapologetically ADHD: A Step-by-Step Framework for Everyday Planning on Your Terms, is out and available now! You can find the hardcover or ebook version via Amazon, Barnes and Noble, Kobo, and Apple Books. Visit https://takecontroladhd.com/adhdbook for direct links to your favorite bookstore online, or visit your neighborhood bookstore and ask for it by name!  ★ Support this podcast on Patreon ★

Join MEMBERS ONLY to get access to perks: https://www.youtube.com/channel/UCSo2azieL7E7uzkXGvEeMSw/join   For only $4.99 a month, get EVERY NEW podcast episode EARLY and AD-FREE. As a member, you'll have access to guest AMAs to get your questions answered. Enjoy the cool elitefts badge next to your profile name as well.      elitefts Apparel: https://www.elitefts.com/shop/apparel.html               Support and help the Podcast grow by Joining The Crew:  https://www.elitefts.com/join-the-crew       Dr. Dwyane Jackson joins us in this 314th episode of Dave Tate's Table Talk Podcast.   Dr. Jackson, a renowned health and performance specialist from Yale University School of Medicine, combines expertise in exercise science, sport psychology, nutrition, and neurovascular physiology into practical applications.   His award-winning research on chronic stress and its effects on immunity, inflammation, and mental health has led to numerous influential publications and presentations. Dr. Jackson's discoveries in skeletal muscle blood flow and performance have advanced our understanding of muscle physiology.   SPONSORS Marek Health   A telehealth platform specializing in hormone optimization and preventative medicine. Offers self-service labs and guided optimization with competitive pricing.  Save 10% on your first order with code TABLETALK. Visit Marek Health today: https://marekhealth.com/tabletalk     LMNT   A zero-sugar, naturally-formulated electrolyte drink mix suited for athletes and those on hydration-focused diets.  Receive a free 8-flavor sample pack with any purchase. https://partners.drinklmnt.com/free-gift-with-purchase?utm_campaign=agwp&rfsn=6760586.28b9b1e&utm_medium=sponsor&utm_source=tabletalk&utm_content=&utm_term=     RP Hypertrophy App An advanced training app designed for maximum muscle growth. Early access pricing starts at $24.99.  Visit the provided link for more details and discounts. https://go.rpstrength.com/hypertrophy-app/   CODE: TABLE TALK   elitefts   Offers a wide range of gym equipment and apparel.  Support the show: https://www.elitefts.com/content/table-talk/   Save 10% with code TABLETALK. CODE: TABLETALK All profits support Dave Tate's Table Talk Podcast. SUPPORT THE SHOW Support and help the Podcast grow by Joining The Crew:  https://www.elitefts.com/join-the-crew  All profits from elitefts Limited Edition Apparel, Table Talk Coffee, and Team elitefts Workouts, Programs, and Training eBooks support Dave Tate's Table Talk Podcast. Shop these elitefts items: https://www.elitefts.com/content/table-talk/       elitefts Shop: https://www.elitefts.com/        elitefts IG: https://www.instagram.com/elitefts/   elitefts Limited Edition Apparel: https://www.elitefts.com/shop/apparel/limited-edition.html

Abelardo Morell joins me to talk about his storied career and incredible passion for photography and art history. We talk about Flowers for Lisa, published by Abrams Books and Tent-Camera, published by Nazraeli Press, including the inspiration and the inventiveness of these works and the work that came before and after. Abe's work has long been fundamental to my teaching practice and his love of the process and the possibilities of photography as an art form still drive him today long after retiring from 30 years of teaching at the Massachusetts College of Art and Design. https://www.abelardomorell.net In the Company of Monet and Constable - Nov 23, 2024 – Feb 17, 2025 https://www.clarkart.edu/exhibition/detail/abelardo-morell-in-the-company-of-monet-and-consta This podcast is sponsored by the Charcoal Book Club Begin Building your dream photobook library today at https://charcoalbookclub.com Abelardo Morell was born in Havana, Cuba in 1948. He immigrated to the United States with his parents in 1962.  Morell received his undergraduate degree from Bowdoin College and his MFA from The Yale University School of Art. He has received an honorary degree from Bowdoin College in 1997 and from Lesley University in 2014. He was professor of Photography at the Massachusetts College of Art and Design in Boston from 1983 to 2010. His publications include a photographic illustration of Alice's Adventures in Wonderland(1998) by Dutton Children's Books, A Camera in a Room(1995) by Smithsonian Press, A Book of Books (2002) and Camera Obscura (2004) by Bulfinch Press and Abelardo Morell(2005), published by Phaidon Press. The Universe Next Door(2013), published by The Art Institute of Chicago.  Tent-Camera (2018), published by Nazraeli Press. Flowers for Lisa (2018), published by Abrams Books. His latest show, Abelardo Morell: In the Company of Monet and Constable, will be at the The Clark Institute in Williamstown, MA, on view November 23, 2024 - February 17, 202

Hangama Amiri, an acclaimed Afghan-Canadian textile artist, joins us to share her remarkable journey from painting to textiles, drawing deeply from her Afghan heritage and personal history. In our conversation, Amiri explains how she transforms fabrics to tell a story with her art and how powerful the medium is to express authenticity and connection.We also shine a light on the resilience of Afghan women through salon culture, a fascinating aspect of Amiri's experiences during her visits to Afghanistan that have become prominent in her work. These salons are more than spaces for beauty—they are bastions of resistance and entrepreneurship in male-dominated settings. Amiri reflects on the art world's often narrow views on textiles and shares insights inspired by her academic journey, challenging the notion that textile art is merely craft. Her experiences at NSCAD and Yale underscore the importance of diversity and representation in fostering artistic growth and confidence.In our final segment, Amiri reflects on her transition to an independent artistic practice and the freedom it offered to develop her unique voice. Aspiring artists will find her advice invaluable: understanding your relationship with your materials and staying true to your intuition as key to authentic expression. ---Hangama Amiri holds an MFA from Yale University, where she graduated in 2020 from the Painting and Printmaking Department. She received her BFA from NSCAD University in Halifax, Nova Scotia, and is a Canadian Fulbright and Post-Graduate Fellow at Yale University School of Art and Sciences (2015-2016). She is also a Kaiserring Stapendiatin of 2023 by Monchehaus Museum in Goslar, Germany. Her recent exhibitions include A Quiet Resistance (2023) at Monchehaus Museum, Goslar, Germany; A Homage to Home (2023) at The Aldrich Contemporary Art Museum, Ridgefield, CT; Sharjah Biennial 15: Thinking Historically in the Present (2023), Sharjah, UAE; Reminiscences (2022) at Union Pacific in London; Henna Night/ Shabe Kheena (2022) at David B. Smith Gallery, Denver, CO; Mirrors and Faces (2021) at Cooper Cole Gallery, Toronto; Wandering Amidst the Colors (2021) at Albertz Benda, New York, NY; Spectators of a New Dawn (2021), Towards Gallery, Toronto; and Bazaar: A Recollection of Home (2020) at T293 Gallery, Rome, Italy.Follow Hangama on InstagramCover photo taken by Denis Gutiérrez-Ogrinc. Connect with us:Madison Beale, HostCroocial, ProductionBe a guest on The Artalogue Podcast

Pluripotent stem cells are defined, in part, by their potential to generate cell types from all three embryonic germ layers. However, it is well known within the field that there is variability in developmental potential between cell lines. This phenomenon, sometimes referred to as lineage bias, is manifest in a variable response of individual cell lines to induction of differentiation into a specific germ layer lineage. Although lineage bias in pluripotent stem cells has been reported for some years, we do not fully understand its molecular basis, or its implications for normal development. The guests on today's program studied functional variation in human PSC lines as they progress through neurectoderm versus mesendoderm lineages and fore- versus hind-brain development. They will discuss the origin and consequences of inter-individual variation in the early events orchestrating human neural development, the extent to which such variation might impact on adult health and disease, and how it might be exploited in stem cell therapy. GuestsRon McKay is the Director of Basic Science at the Lieber Institute and has appointments in multiple departments and the McKusick-Nathans Institute of Genetic Medicine at the Johns Hopkins School of Medicine, USA. He currently serves as a member of the Stem Cell Reports Editorial Board. Suel-Kee Kim is an Associate Research Scientist in the Department of Neuroscience at Yale University School of Medicine, USA. Seungmae Seo is an Assistant Professor at University of Maryland Eastern Shore, USA. Seungmae is a former ISSCR Merit and Travel Award Winner. HostMartin Pera, Editor-in-Chief, Stem Cell Reports and The Jackson Laboratory@martinperaJAXSupporting ContentIndividual variation in the emergence of anterior-to-posterior neural fates from human pluripotent stem cells, Stem Cell ReportsAbout Stem Cell ReportsStem Cell Reports is the open access, peer-reviewed journal of the International Society for Stem Cell Research (ISSCR) for communicating basic discoveries in stem cell research, in addition to translational and clinical studies. Stem Cell Reports focuses on original research with conceptual or practical advances that are of broad interest to stem cell biologists and clinicians.X: @StemCellReportsAbout ISSCRWith nearly 5,000 members from more than 80 countries, the International Society for Stem Cell Research (@ISSCR) is the preeminent global, cross-disciplinary, science-based organization dedicated to stem cell research and its translation to the clinic. The ISSCR mission is to promote excellence in stem cell science and applications to human health.ISSCR StaffKeith Alm, Chief Executive OfficerYvonne Fisher, Managing Editor, Stem Cell ReportsKym Kilbourne, Director of Media and Strategic CommunicationsJack Mosher, Scientific AdvisorVoice WorkBen Snitkoff

BUFFALO, NY- October 21, 2024 – A new #research paper was #published in Oncotarget's Volume 15 on October 1, 2024, entitled, “Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition.” As highlighted in the abstract, monoclonal antibody therapies for cancer have shown extraordinary clinical success in recent years. However, these strategies are primarily limited to targeting specific cell surface antigens, despite many disease targets being located intracellularly. In their paper, researchers Madison Rackear, Elias Quijano, Zaira Ianniello, Daniel A. Colón-Ríos, Adam Krysztofiak, Rashed Abdullah, Yanfeng Liu, Faye A. Rogers, Dale L. Ludwig, Rohini Dwivedi, Franziska Bleichert, and Peter M. Glazer from the Departments of Therapeutic Radiology and Genetics at Yale University School of Medicine, Gennao Bio, and the Department of Molecular Biophysics and Biochemistry at Yale University report on the humanization of the full-length, nucleic acid-binding monoclonal lupus-derived autoantibody 3E10, which exhibits a novel mechanism for cell penetration and tumor-specific targeting. The authors compare humanized variants of 3E10 and demonstrate that cell uptake relies on the nucleoside transporter ENT2. They also find that faster cell uptake and superior in vivo tumor targeting are associated with higher affinity nucleic acid binding. “We show that one human variant retains the ability of the parental 3E10 to bind RAD51, serving as a synthetically lethal inhibitor of homology-directed repair in vitro.” DOI - https://doi.org/10.18632/oncotarget.28651 Correspondence to - Peter M. Glazer - peter.glazer@yale.edu Video short - https://www.youtube.com/watch?v=sTHjJ0Qq0YQ Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28651 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, 3E10, cell penetration, nucleic acid binding, nucleic acid delivery, RAD51 About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science). To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

Thomas N. Seyfried is an American professor of biology, genetics, and biochemistry at Boston College who has been published in over 150 peer-reviewed publications. He received his PhD from the University of Illinois Urbana-Champaign in 1976. His postdoctoral fellowship studies were in the Department of Neurology at the Yale University School of Medicine where he served as an assistant professor in neurology. His research focuses on mechanisms of chronic diseases such as cancer, epilepsy, neurodegenerative lipid storage diseases, and caloric restriction diets. https://tomseyfried.com/donate/ Thanks to our sponsor: Nutritionwithconfidence.com

In Episode 170, we have a frank discussion with Dr. Dwayne Jackson about the ins-and-outs of testosterone deficiencies and the need for individuals to seek out supplemental testosterone replacement therapy (TRT).  It is more and more common to hear about males seeking out TRT for lifestyle and aesthetic reasons.  However, do they truly need to replace testosterone from a clinical standpoint, or are they compensating for poor lifestyle choices, bad or non-existent exercise habits or simply not exhausting conventional methods of managing their testosterone and general health?  Dr. Jackson provides an overview of all of the possible causes of low testosterone, as well as possible reasons for these deficiencies.  For those that are willing to examine their lifestyle choices and make changes, improvements in testosterone levels can be achieved.  But, in some cases, testosterone therapy may be a reasonable option when all of the conventional options have been exhausted.  Dr. Dwayne N. Jackson is a dad, athlete, health specialist, medical educator, scientist, and entrepreneur. He has over 12 years of university education in exercise/human physiology, medicine, and nutritional biochemistry. Dr. Jackson holds a PhD in neurovascular physiology and has been educated at some of the top academic institutions in North America including University of Ottawa, the University of Western Ontario, and Yale University School of Medicine.  You can find out more information on Dr. Dwayne Jackson below:  Instagram:                   https://www.instagram.com/drdnjackson/  Website:                      https://drdwaynejackson.com/              The D&D Fitness Radio podcast is available at the following locations for downloadable audio, including:  iTunes – https://itunes.apple.com/us/podcast/d-d-fitness-radio-podcast/id1331724217  iHeart Radio – https://www.iheart.com/podcast/dd-fitness-radio-28797988/  Spreaker.com – https://www.spreaker.com/show/d-and-d-fitness-radios-show  Spotify –  https://open.spotify.com/show/5Py2SSPA4mntNwYRm0Opri    You can reach both Don and Derek at the following locations:  Don Saladino: http://www.DonSaladino.comTwitter and Instagram - @DonSaladinoYouTube - http://www.youtube.com/donsaladino  Derek M. Hansen: http://www.SprintCoach.comTwitter and Instagram - @DerekMHansenYouTube - http://youtube.com/derekmhansen

David L. Katz, MD, MPH is a specialist in Preventive Medicine and Lifestyle Medicine, with particular expertise in nutrition. He earned his BA at Dartmouth College (1984); his MD at the Albert Einstein College of Medicine (1988); and his MPH from the Yale University School of Public Health (1993). He completed sequential residency training and board certification in Internal Medicine (1991) and Preventive Medicine/Public Health (1993). Katz is the founder and former director of Yale University's Yale-Griffin Prevention Research Center (1998-2019); Past President of the American College of Lifestyle Medicine; President and Founder of the non-profit True Health Initiative; and Founder and CEO of Diet ID, Inc. The recipient of numerous awards for teaching, writing, and contributions to public health, Katz was a 2019 James Beard Foundation Award nominee in health journalism, has been a widely supported nominee for the position of U.S. Surgeon General, and has received three honorary doctorates. Katz has served as a nutrition columnist for O, the Oprah Magazine; an on-air contributor for ABC News/Good Morning America, and with appearances on most major news programs and contributions to most major magazines and leading newspapers, including OpEds in the New York Times and Wall Street Journal. His most recent book, How to Eat, co-authored with Mark Bittman, is a 2021 IACP Awards finalist and is worth your time. I have had the pleasure of hearing him speak many times over the years and he is an amazing orator and I am blessed to have this hour with him. Today, we dive into the science of childhood obesity and what are the public health pain points that can be pressed on to change the negative trajectory. Enjoy, Dr. M

The digital age has made it easier than ever to access health information, but how can we know which sources to trust? Social media is saturated with misinformation. Some of it is inadvertent — many bold pseudoscientific claims seem very convincing, and anyone could be forgiven for sharing it with the best intentions. But, a more deliberate manipulation of scientific information has become commonplace, often used to push certain narratives or turn a profit. Combating this misinformation machine can feel impossible. So, we assembled five experts from different corners of the science communication community to help equip you for the fight: Dr. David L. Katz, MD, MPH, a renowned figure in the field of preventive medicine, public health, and nutrition. (Website: https://davidkatzmd.com/) Steven Novella MD, clinical neurologist and associate professor at Yale University School of Medicine, a host of The Skeptics' Guide to the Universe podcast, and a founder of the New England Skeptical Society. (Website: https://theness.com/neurologicablog/) Dr. Jessica Steier PhD, public health scientist and host of the wildly popular Unbiased Science podcast. (Instagram: https://www.instagram.com/unbiasedscipod) Dr. Jonathan Stea PhD,  clinical psychologist and author of the book ‘Mind the Science'. (Instagram: https://www.instagram.com/dr_jonathan_stea/ / Website: https://www.jonathanstea.com/) Dr. Idrees Mughal, AKA ‘Dr. Idz', one of the most popular online misinformation-debunking social media icons. (TikTok: https://www.tiktok.com/@dr_idz / Website: https://www.schoolofdridz.com/) Together, we discuss: • The telltale signs of pseudoscientific messaging. • Where misinformation comes from, and why it often spreads faster than evidence-based facts. • Why we can be so susceptible to believing misinformation. • Who profits by poisoning the science communication space. • How we can improve our scientific literacy and avoid echo chambers. • Ways academics can improve their public health communication. • ‘Your Brain On' is hosted by neurologists, scientists and public health advocates Ayesha and Dean Sherzai. ‘Your Brain On... Misinformation' • SEASON 3 • EPISODE 9

Today, I am blessed to have Dr. Thomas Seyfried here with me. Thomas N. Seyfried received his Ph.D. in Genetics and Biochemistry from the University of Illinois, Urbana, in 1976. He did his undergraduate work at the University of New England, where he recently received the distinguished Alumni Achievement Award. He also holds a Master's degree in Genetics from Illinois State University. Thomas Seyfried served with distinction in the United States Army's First Cavalry Division during the Vietnam War and received numerous medals and commendations. He was a Postdoctoral Fellow in the Department of Neurology at the Yale University School of Medicine and then served on the faculty as an Assistant Professor in Neurology. Dr. Seyfried argues that cancer is a metabolic disease, not a genetic one, and suggests that lifestyle factors play a role in its development. He highlights that if you wanted to get cancer, you would adopt a sedentary lifestyle, consume highly processed foods with long shelf lives, avoid fresh food, experience high levels of emotional stress, and deprive yourself of sleep. He notes that many people engage in these behaviors unknowingly, leading to increased rates of cancer, diabetes, obesity, and other chronic diseases. Seyfried's point is that to prevent cancer, individuals should focus on maintaining metabolic health through exercise, proper diet, stress management, and quality sleep. Dr. Seyfried highlights that the current medical understanding of cancer is rooted in the idea that it is a genetic disease, a concept taught in medical schools and upheld by oncologists. These professionals are trained to use traditional treatments like chemotherapy and radiation, focusing on managing toxicity rather than addressing the root cause. Seyfried argues that cancer is a metabolic disease driven by glucose and glutamine, but this crucial information is missing from training. He emphasizes the need for metabolic therapy, which targets the fuels cancer cells depend on while keeping healthy cells thriving, notably through ketosis. He expresses frustration at the medical community's resistance to acknowledging this approach despite mounting evidence that metabolic interventions could starve cancer cells and slow tumor growth. Tune in as Dr. Seyfried explains that while animals are hardwired to eat for survival, humans, with conscious awareness, can override this instinct, which can lead to disorders like anorexia. He highlights that modern diets, full of processed carbohydrates and fats, are far removed from what our ancestors ate, causing health issues like obesity, type 2 diabetes, and cancer. Additionally, he critiques the financial burden of cancer treatments, calling the system immoral, especially for the economically disadvantaged. Resources from this episode:  Website: https://tomseyfried.com/ Cancer as a Metabolic Disease: https://www.amazon.com/Cancer-Metabolic-Disease-Management-Prevention/dp/0470584920/benazadi-20 Donate: https://www.bc.edu/bc-web/offices/alumni/giving.html

Over 103,000 people need organ donations in the U.S. Some economists and health experts wonder whether creating a free or regulated market would resolve this. Those in support argue that with proper regulations, it can be safe, ethical, and financially beneficial for both sellers and buyers. Those against this have ethical concerns and point out the risk of abuse and undermining of the medical system. Now we debate: Should We Legalize the Market for Human Organs? Arguing Yes: Sally Satel, Psychiatrist, Senior Fellow at the American Enterprise Institute, and Lecturer at the Yale University School of Medicine  Arguing No: Jeremy Chapman, Editor-in-Chief of The Transplantation Journal and Past President of the International Transplantation Society    Emmy award-winning journalist John Donvan moderates  Learn more about your ad choices. Visit podcastchoices.com/adchoices

Dr. Sarah Elizabeth Lewis has one of the most illustrious resumés of all the guests on Pulling the Thread—and I think we're the same age. Lewis is the John L. Loeb Associate Professor of the Humanities and Associate Professor of African and African American Studies at Harvard University where she serves on the Standing Committee on American Studies and Standing Committee on Women, Gender, and Sexuality. It was at Harvard that Lewis pioneered the course Vision and Justice: The Art of Race and American Citizenship, which she continues to teach and is now part of the University's core curriculum—as it were, Lewis is the founder of Vision & Justice, which means that she is the organizer of the landmark Vision & Justice Convening, and co-editor of the Vision & Justice Book Series, launched in partnership with Aperture. Before joining the faculty at Harvard, she held curatorial positions at The Museum of Modern Art, New York and the Tate Modern, London. She also served as a Critic at Yale University School of Art. I'm not done—in fact, I could go on and on. She's the author of The Rise: Creativity, the Gift of Failure, and the Search for Mastery, a book on Carrie Mae Weems, and innumerable important academic papers. Today, we talk about The Rise and how it dovetails in interesting ways with her brand-new book, The Unseen Truth: When Race Changed Sight in America, which is about the insidious idea that white people are from the Caucasus, a.k.a. Caucasian—an idea that took root in the culture and helped determine the way we see race today.  MORE FROM SARAH ELIZABETH LEWIS, PhD: The Unseen Truth: When Race Changed Sight in America The Rise: Creativity, the Gift of Failure, and the Search for Mastery Carrie Mae Weems Sarah Lewis's Website Vision & Justice Follow Sarah on Instagram To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Dr. Sandra Hassink is joined by Dr. Mona Sharifi, and Dr. Sarah Armstrong. Dr. Sharifi is an Associate Professor of Pediatrics (General Pediatrics) and of Biomedical Informatics and Data Science, at the Yale University School of Medicine; as well as the Chief of Pediatrics. Dr. Armstrong is a Professor of Pediatrics and Populations Health Sciences, and the Division Chief of General Pediatrics and Adolescent Health at Duke. Related Resources: • Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents with Obesity (tinyurl.com/yc53upmr) • Obesity CPG Homepage (tinyurl.com/52nz6m2m) • US Preventive Services Task Force Recommendation Statement (tinyurl.com/3rxb794v)

Guest: Dr. Lynn Kirkpatrick Chief Executive Officer, Ensysce Biosciences Inc. Ticker: $ENSC (NASDAQ) Website: https://ensysce.com/ Bio: Dr. Lynn Kirkpatrick Chief Executive Officer, Ensysce Biosciences Inc. Dr. Kirkpatrick has focused her entire career on drug discovery and development. Former Professor of Chemistry and Biochemistry in Canada, she has been active in both the novel drug discovery as well as clinical development of drug candidates throughout her career. She co-founded three start-up companies and successfully brought three novel cancer drug candidates and two other drug candidates in pain and infectious diseases from bench into human clinical trials. Following the acquisition of the first company she co-founded, ProlX Pharmaceuticals, she became President and CEO of Ensysce Biosciences Inc. and took the company public in 2021. Now Dr. Kirkpatrick is guiding the clinical development of Ensysce's highly novel pain products, which use compelling chemical approaches to reduce abuse and overdose potential. Dr. Kirkpatrick received her PhD in Medicinal Chemistry from the University of Saskatchewan and completed a post-doctoral fellowship in Pharmacology at Yale University School of Medicine before returning to Canada where she spent 16 years in academia. She has published extensively in the area of targeted cancer drug discovery and development and holds numerous patents for novel drug candidates. Company Bio: Ensysce Biosciences is developing first-in-class and uniquely innovative solutions in oral drug delivery. Our proprietary TAAP™ and MPAR® technologies improve the care and safety of patients by preventing the possibility of both abuse and overdose of prescription drugs. Our mission is to revolutionize the safety and oral delivery of medicines for areas of high unmet need. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

Dr. Dwayne N. Jackson is a dad, athlete, health specialist, medical educator, scientist, and entrepreneur. He has over 12 years of university education in exercise/human physiology, medicine, and nutritional biochemistry. Dr. Jackson holds a PhD in neurovascular physiology and has been educated at some of the top academic institutions in North America including University of Ottawa, the University of Western Ontario, and Yale University School of Medicine. He can be found at: https://drdwaynejackson.com/about/ --- Support this podcast: https://podcasters.spotify.com/pod/show/thefitfarmingfoodmom/support

The great fusionist project of ordered liberty advocated by Frank Meyer, William F. Buckley, and M. Stanton Evans is defended and affirmed today by a group calling themselves Freedom Conservatives, or FreeCons.  And as most groups of conservatives are wont to do, they have drafted a Statement of Principles outlining what they hope to affirm.  Saving Elephants host Josh Lewis is a proud signatory on this statement and welcomes in this episode one of the two originators of the Statement, Avik Roy, for a wide-ranging discussion on fusionism, how FreeCons may compare and contrast with NatCons, the need for conservatism to grapple with issues of equality, and much more.   About Avik Roy Excerpts from https://bipartisanpolicy.org/person/avik-roy/   Avik Roy is the President of the Foundation for Research on Equal Opportunity (FREOPP.org), a non-partisan, non-profit think tank that conducts original research on expanding opportunity to those who least have it.  Roy's work has been praised widely on both the right and the left. National Review has called him one of the nation's “sharpest policy minds,” while the New York Times' Paul Krugman described him as man of “personal and moral courage.”   Roy has advised three presidential candidates on policy, including Marco Rubio, Rick Perry, and Mitt Romney.  Roy also serves as the Opinion Editor at Forbes, where he writes on politics and policy, and manages The Apothecary, the influential Forbes blog on health care policy and entitlement reform.  [He] is the author of How Medicaid Fails the Poor, published by Encounter Books in 2013, and Transcending Obamacare: A Patient-Centered Plan for Near-Universal Coverage and Permanent Fiscal Solvency, a second edition of which was published in 2016 by FREOPP.  He serves on the advisory board of the National Institute for Health Care Management, is a Senior Advisor to the Bipartisan Policy Center, and co-chaired the Fixing Veterans Health Care Policy Taskforce.   Roy's writing has also appeared in The Wall Street Journal, The New York Times, The Washington Post, USA Today, The Atlantic, National Review, The Weekly Standard, and National Affairs, among other publications.  He is a frequent guest on television news programs, including appearances on Fox News, Fox Business, NBC, MSNBC, CNBC, Bloomberg, CBS, PBS, and HBO.   From 2011 to 2016, Roy served as a Senior Fellow at the Manhattan Institute for Policy Research, where he conducted research on the Affordable Care Act, entitlement reform, universal coverage, international health systems, and FDA policy.  Previously, he served as an analyst and portfolio manager at Bain Capital, J.P. Morgan, and other firms.   Roy was educated at the Massachusetts Institute of Technology, where he studied molecular biology, and the Yale University School of Medicine.  You can follow Roy on Twitter @Avik  

Welcome to another episode Libration Nation! Today, we're diving deep into the surreal and thought-provoking world of Victor Pelevin's "Generation P," also known as "Homo Zapiens" in English. Joining us is Pelevin aficionado Dr. Albert Arias, and we unravel the complex tapestry of post-Soviet Russia's chaotic transition to capitalism, examining the Western cultural invasion and the profound philosophical layers infused with Buddhism and spirituality that Pelevin navigates in his works We'll also chatter about the intriguing film adaptation, the psychedelic journeys depicted in the narrative, and the eerie foresight of fictional leaders born from deep fakes.Dr. Arias is a graduate of Michigan State University's College of Human Medicine (2001), and he completed his residency in psychiatry as well as a master's degree in clinical and translational research at the University of Connecticut Health Center. He was on the faculty at UCONN School of Medicine and then went on to be a faculty member at Yale University School of Medicine for 7 years in the department of psychiatry before joining VCU in 2018 as an associate professor and the Associate Division Chair for Addiction Psychiatry. He is the current President of the Psychiatric Society of Virginia.Dr. Arias' current research focuses on studying the effects of medications on mood disorders and addictions.We paired the book with Moscow Mules as a tie-in with the author's home country.Moscow Mule*.5 ounce lime juice2 ounces vodka4 fluid ounces ginger beer, or to tasteLime wedge for garnish*Not required, but generally served in a copper cupIn this episodeBooks by Victor PelevinVictor Pelevin, Russia's most mysterious modern writerFilm Adaptation

Jaimey was diagnosed with prostate cancer in 2008. He was treated and received a clean bill of health and remained cancer-free. In May 2015, a routine blood donation led to a life-changing discovery when the Red Cross director urged him to seek immediate medical attention. Jaimey was diagnosed with chronic lymphocytic leukemia (CLL), which, contrary to its typical slow progression, advanced rapidly in his case. Jaimey remained active, cycling and running to maintain his mental well-being.However, six to nine months ago, his CLL numbers began to rise again, promptingdiscussions about future treatments. Although his white blood cell count is high and he has low antibodies, making illnesses particularly severe, Jaimey remains optimistic with Dana-Farber's support. After obtaining an A.B. cum laude in chemistry at Harvard College, Dr. Davidscompleted his M.D. cum laude at Yale University School of Medicine. He served as an intern, resident, and assistant chief resident in internal medicine at NewYork-Presbyterian Weill Cornell Medical Center and Memorial Sloan-Kettering Cancer Center in New York City. He then completed his fellowship in hematology and oncology in Dana-Farber/Partners CancerCare, and a Masters in Medical Science (M.M.S.c.) at Harvard Medical School. He is an attending physician in the Division of Lymphoma, and serves as the Director of Clinical Research, as well as Associate Director of the CLL Center. He is also an Associate Professor of Medicine at Harvard Medical School, and attends on the inpatient hematologic malignancies service at Brigham and Women's Hospital. Acute lymphocytic leukemia is the most common type of cancer in children, andtreatments result in a good chance for a cure. Acute lymphocytic leukemia can also occur in adults, though the chance of a cure is greatly reduced.

Stat: 11%: An estimated 11% of U.S. adults who have ever had COVID-19 are currently experiencing symptoms of long COVID, which can last three months or longer. This suggests that millions of people across the country could be affected. Story: Long COVID is a health condition that's continuing to puzzle scientists. Since the outbreak of COVID-19, doctors saw some patients who would recover quickly, while other people's symptoms continued to worsen—and many symptoms varied widely and lasted long after the initial infection. In this episode of “From Lab to Life,” Keyla Sá, a researcher at Yale University School of Medicine, discusses her work tracking how long COVID develops and a new artificial intelligence tool that can identify the infection's symptoms and patterns that scientists might not normally recognize.

There is a lot of common summertime advice. For example, don't go swimming for a half hour after you eat. Don't scratch a bug bite. Don't touch someone who has poison ivy because you might catch it. Are these things true or summertime folklore? This episode starts with some answers. https://www.silive.com/healthfit/2012/07/summer_myths_debunked.html Do you know what toxic positivity is? It's the philosophy that says to look on the bright side. Try to stay positive no matter what. Don't worry – everything's going to be just fine. We often say these things to comfort people, but it may be doing more harm than good. That's according to my guest, Whitney Goodman. She is a licensed marriage and family therapist and author of the book, Toxic Positivity: Keeping It Real in a World Obsessed With Being Happy (https://amzn.to/3cwrhcf).  You may know your chronological age, but do you know your biological age? There is pretty strong evidence that how you live your life can accelerate or roll back your biological age, according to my guest, Morgan Levine. She is an assistant professor of pathology at Yale University School of Medicine and author of the book, True Age: Cutting-Edge Research to Help Turn Back the Clock (https://amzn.to/3zaRepw). Listen as she explains what you can do to slow or reverse the aging process so you stay as young as you can for as long as you can.  The old advice to, “Stop and smell the roses” may be more important than you ever thought. It appears the scent of a rose can improve your memory, your dreams and even your happiness. Listen as I explain. https://www.dailymail.co.uk/sciencetech/article-1059329/How-sweet-dreams–simply-smell-roses.html and https://www.nature.com/news/2007/070305/full/news070305-10.html Learn more about your ad choices. Visit megaphone.fm/adchoices

People who are good at their jobs routinely get promoted into bigger jobs they're bad at. We explain why firms keep producing incompetent managers — and why that's unlikely to change. SOURCES:Nick Bloom, professor of economics at Stanford University.Katie Johnson, freelance data and analytics coach.Kelly Shue, professor of finance at the Yale University School of Management.Steve Tadelis, professor of economics at the University of California, Berkeley Haas School of Business. RESOURCES:“People Management Skills, Employee Attrition, and Manager Rewards: An Empirical Analysis,” by Mitchell Hoffman and Steven Tadelis (Journal of Political Economy, 2021).“Promotions and the Peter Principle,” by Alan Benson, Danielle Li, and Kelly Shue (The Quarterly Journal of Economics, 2019).“Bosses Matter: The Effects of Managers on Workers' Performance,” by Kathryn L. Shaw (IZA World of Labor, 2019).“The Value of Bosses,” by Edward P. Lazear, Kathryn L. Shaw, and Christopher T. Stanton (Journal of Labor Economics, 2015).The Peter Principle: Why Things Always Go Wrong, by Laurence J. Peter and Raymond Hull (1969). EXTRAS:“The Secret Life of C.E.O.s” series by Freakonomics Radio.“What Does a C.E.O. Actually Do?” by Freakonomics Radio (2018).

Simple tools you can knit into your life both for when you're actively freaking out, and for preventing future trips down the anxiety toilet. Dr. Jenny Taitz is a clinical psychologist and an assistant clinical professor in psychiatry at the University of California, Los Angeles. Dr. Taitz completed her fellowship in psychology at Yale University School of Medicine and achieved board certifications in both cognitive behavioral therapy and dialectical behavior therapy. Her new book, Stress Resets: How to Soothe Your Body and Mind in Minutes, is out now. In this episode we talk about:The difference between stress and anxietyJenny's take on the use of benzodiazepinesWhat she means by, “negative core beliefs”, and how to untangle ourselves from themHow to prepare in advance for stressful situationsThe benefit of giving yourself a deliberate panic attackAnd why stress, while uncomfortable, is actually part of a healthy and meaningful lifeAdditional Links: How to Be Single and Happy by Dr. Jenny TaitzBreathe • Calm down • Meditate Three-Minute Breathing SpaceRelated Episodes:Can Anxiety Be a Gift? | Dr. David RosmarinZach Braff On: Anxiety, Sobriety, Insomnia, Grief, Social Media, and the Meaning of the Tattoo on His WristFor tickets to Dan Harris: Celebrating 10 Years of 10% Happier at Symphony Space: click hereSign up for Dan's weekly newsletter hereFollow Dan on social: Instagram, TikTokTen Percent Happier online bookstoreSubscribe to our YouTube ChannelOur favorite playlists on: Anxiety, Sleep, Relationships, Most Popular EpisodesFull Shownotes: https://www.tenpercent.com/tph/podcast-episode/jenny-taitz-730See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.